Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wockhardt Limited ( (IN:WOCKPHARMA) ) has shared an update.
Wockhardt Limited has been assigned an overall ESG score of 65, rated as “Aspiring,” for 2025 by NSE Sustainability Ratings and Analytics, a SEBI-registered ESG rating provider. The assessment, based solely on public disclosures and information, reflects component scores of 51 for Environmental, 70 for Social, and 74 for Governance, highlighting the company’s strong governance and social practices alongside developing environmental performance.
The company emphasized that it did not engage NSE Sustainability Ratings and Analytics for this evaluation, which was conducted independently, underscoring growing third-party interest in Wockhardt’s ESG profile. The rating signals steady progress and solid transparency in ESG matters, which may strengthen the firm’s positioning with investors and other stakeholders who increasingly weigh sustainability metrics in capital-allocation decisions.
More about Wockhardt Limited
Wockhardt Limited is an Indian pharmaceutical company listed on the BSE and NSE under the symbol WOCKPHARMA. The company operates in the healthcare and pharma sector, focusing on research, manufacturing, and marketing of pharmaceutical products for domestic and international markets.
Average Trading Volume: 77,640
Technical Sentiment Signal: Buy
Current Market Cap: 226.8B INR
For detailed information about WOCKPHARMA stock, go to TipRanks’ Stock Analysis page.